AR011178A1 - Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto - Google Patents
Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuestoInfo
- Publication number
- AR011178A1 AR011178A1 ARP980100948A ARP980100948A AR011178A1 AR 011178 A1 AR011178 A1 AR 011178A1 AR P980100948 A ARP980100948 A AR P980100948A AR P980100948 A ARP980100948 A AR P980100948A AR 011178 A1 AR011178 A1 AR 011178A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- preparation
- treatment
- sodium salt
- ilideno
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- -1 SODIUM SALT COMPOUND Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 231100000189 neurotoxic Toxicity 0.000 abstract 1
- 230000002887 neurotoxic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011178A1 true AR011178A1 (es) | 2000-08-02 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100948A AR011178A1 (es) | 1997-03-05 | 1998-03-03 | Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (is) |
| JP (1) | JP2001513796A (is) |
| KR (1) | KR20000075907A (is) |
| CN (1) | CN1249750A (is) |
| AP (1) | AP9901637A0 (is) |
| AR (1) | AR011178A1 (is) |
| AU (1) | AU6825198A (is) |
| BG (1) | BG103779A (is) |
| BR (1) | BR9808305A (is) |
| CA (1) | CA2282851A1 (is) |
| CO (1) | CO4940415A1 (is) |
| EA (1) | EA199900710A1 (is) |
| EE (1) | EE9900387A (is) |
| GB (1) | GB9704498D0 (is) |
| HR (1) | HRP980114A2 (is) |
| HU (1) | HUP0002109A2 (is) |
| ID (1) | ID24207A (is) |
| IL (1) | IL131489A0 (is) |
| IS (1) | IS5166A (is) |
| NO (1) | NO994303L (is) |
| NZ (1) | NZ337315A (is) |
| OA (1) | OA11154A (is) |
| PE (1) | PE51399A1 (is) |
| PL (1) | PL335652A1 (is) |
| SK (1) | SK119699A3 (is) |
| TR (1) | TR199902117T2 (is) |
| WO (1) | WO1998039327A1 (is) |
| YU (1) | YU43499A (is) |
| ZA (1) | ZA981791B (is) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| AU2018284335A1 (en) | 2017-06-12 | 2020-01-30 | Glytech Llc. | Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Ceased
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Withdrawn
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6825198A (en) | 1998-09-22 |
| ID24207A (id) | 2000-07-13 |
| BG103779A (en) | 2000-06-30 |
| SK119699A3 (en) | 2000-05-16 |
| TR199902117T2 (xx) | 2000-03-21 |
| KR20000075907A (ko) | 2000-12-26 |
| JP2001513796A (ja) | 2001-09-04 |
| PE51399A1 (es) | 1999-06-07 |
| IL131489A0 (en) | 2001-01-28 |
| CO4940415A1 (es) | 2000-07-24 |
| CA2282851A1 (en) | 1998-09-11 |
| AP9901637A0 (en) | 1999-09-30 |
| EA199900710A1 (ru) | 2000-04-24 |
| EE9900387A (et) | 2000-04-17 |
| CN1249750A (zh) | 2000-04-05 |
| NZ337315A (en) | 2001-02-23 |
| HUP0002109A2 (hu) | 2001-04-28 |
| BR9808305A (pt) | 2000-05-16 |
| GB9704498D0 (en) | 1997-04-23 |
| EP0966463A1 (en) | 1999-12-29 |
| HRP980114A2 (en) | 1998-12-31 |
| IS5166A (is) | 1999-08-27 |
| PL335652A1 (en) | 2000-05-08 |
| YU43499A (sh) | 2000-12-28 |
| OA11154A (en) | 2003-04-16 |
| WO1998039327A1 (en) | 1998-09-11 |
| NO994303L (no) | 1999-11-03 |
| ZA981791B (en) | 1999-09-03 |
| NO994303D0 (no) | 1999-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT915898E (pt) | Forma i cristalina de claritromicina | |
| BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| BR0212787A (pt) | Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica | |
| ES2129485T3 (es) | Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion. | |
| AR019496A1 (es) | Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos | |
| ZA959451B (en) | 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these | |
| FI934298A0 (fi) | Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning | |
| BR9507381A (pt) | Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos | |
| AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
| BR9611276A (pt) | Composto formulação farmacêutica processo para tratamento ou profilaxia de doenças ou condições de seres humanos e uso de um composto | |
| MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
| BR0011339A (pt) | Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase | |
| AR011178A1 (es) | Compuesto de sal de sodio de (acido (e) 4,6-dicloro-3-(2-oxo-1- fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico en su forma hidratada,proceso para su preparacion, composicion farmaceutica que lo contiene y metodo de tratamiento utilizando dicho compuesto | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| AR002191A1 (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion | |
| AR031126A1 (es) | Acidos amino(oxo)aceticos inhibidores de la proteina tirosina fosfatasa | |
| NO20020914D0 (no) | Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav | |
| DE69709891D1 (de) | Chitosan enthaltende zusammensetzung | |
| ES2065855B1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
| ES2121293T3 (es) | Uso de trovafloxacina o derivados de la misma para la fabricacion de un medicamento para el tratamiento de infecciones por h. pylori. | |
| BR0317425A (pt) | Sal de rabeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação | |
| MX9704035A (es) | 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos. | |
| ZA824649B (en) | New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds |